Somite AI Raises $47M Series A to Revolutionize Cell Therapy
Somite AI Raises $47M Series A to Revolutionize Cell Therapy
Other news
Investor notes | Breaking the cell therapy bottlenecks with AI foundational models
Ascend adds new board members
Ajinomoto Group Ventures co-leads investment in Enhanced Medical Nutrition
